Search Results

research have highlighted the disagreements over the contribution of animal research in the development of vaccines -19 vaccine development. The scientific community is under pressure, pressure from the political parties on how to develop a vaccine While Mr van der Laan countered by asking how vaccine studies can be set up with no prediction of what -19 vaccine trials and to discuss the preclinical data required to support proceeding to first-in-human

are both on the 3Rs in coronavirus research and will discuss new strategies for the development of vaccines website, contributions are being sought from researchers on the question Is there a role for the 3Rs in Covid

A cancer vaccine being developed, in the Netherlands, has been found to be effective in treating multiple Maastricht, Amsterdam UMC, and from the School of Pharmaceutical Science, Switzerland, have developed a vaccine mice and pet dogs suffering from cancer, published in Nature Communications, show that the vaccine The researchers treated 35 dogs, suffering from bladder and bone cancer, with the vaccine - half of them The team hope that this research will contribute to a cancer vaccine that also works for humans.

A significant disagreement, on the use of an animal model in vaccine safety testing, has developed between natural property in the blood of horseshoe crabs, has been essential for testing the safety of new vaccines Now with the demand from US companies for sterility testing for Covid-19 vaccines, using horseshoe crabs increase there are concerns for it’s an effect on the populations of the animal and also that European vaccines -19 vaccine development process would not result in the need for harvesting significantly more than usual

Her captivating talk delved into the intricate challenges of developing vaccines for outbreak viruses , encompassing not only the COVID-19 pandemic, for which she spearheaded the groundbreaking Oxford/AstraZeneca  vaccine, but also lesser-known diseases worldwide that pose a potential threat in the near future due There is an increased focus on using human organoids to test vaccines and look at immune responses, but

Scientists at Yale University School of Medicine, USA, have developed a vaccine against Lyme disease, based on the same technology used for the Covid-19 vaccine. The team showed, in guinea pigs, that the mRNA vaccine offered protection against the infection that According to the findings, in Science Translational Medicine, the vaccine teaches the immune system to multiple tick-borne diseases, and this approach potentially offers more broad-based protection than a vaccine

US researchers have shown the effects of Covid-19 infection in three different species of monkey. rhesus macaques, baboons and marmosets - and identifies which would be suitable models to test new vaccines Hence, these monkeys can be used to help better model the variation of Covid-19 infection

scientist at EARA member Complutense University of Madrid, Spain, is at the forefront of efforts to find a vaccine is the co-ordinator of the EU-funded global consortium, VACDIVA, that is testing three possible ASF vaccines He told The Guardian: “While it is possible to eradicate ASF without vaccination, it takes a long time If large-scale trials show that the vaccine candidates are safe and effective, he hoped that a vaccine

ISC-PIF, France, has created a series of knowledge maps to identify key areas of study relating to Covid Key terms relating to Covid-19 are represented by a dot on the map with lines connecting it to related research can be identified by searching for different animal models, for example a search for mice in the Covid

The first booster vaccines, targeting the Omicron variant of Covid-19, have been authorised by regulators that at a meeting with the FDA, Pfizer showed that compared with the mice that received the original vaccine say clinical trials will begin next month - clinical data is still needed for full approval of the vaccines The action by regulators is in line with procedures for annually reformulated influenza vaccines, which to undergo new clinical trials unless the manufacturers significantly change the way they make the vaccine

The World Health Organization has approved a landmark vaccine against malaria for widespread rollout The vaccine, developed thanks to 30 years of research by EARA member GSK, including in mice and non-human Trials showed that the vaccine, known as Mosquirix, was able to prevent four in 10 cases of malaria, “Using this vaccine in addition to existing tools to prevent malaria could save tens of thousands of Earlier this year, a trial of a separate anti-malaria vaccine developed by the Jenner Institute of Oxford

variety of animals are now being used to produce and understand the antibodies that can fight against Covid Biotherapeutics, USA, are using genetically modified cows to produce human antibodies that can neutralise Covid modified mice to generate human antibodies when searching for the optimal mix of antibodies to fight off Covid